메뉴 건너뛰기




Volumn 75, Issue 1, 2002, Pages 95-99

Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor

Author keywords

Factor VIII inhibitor; Hemarthropathy; Hemophilia; NovoSeven; Total knee replacement

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 8A; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; ALLOANTIBODY; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; HYBRID PROTEIN;

EID: 0036363475     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02981987     Document Type: Article
Times cited : (13)

References (40)
  • 2
    • 0023924034 scopus 로고
    • Total knee replacement in haemophilic arthropathy
    • Karthaus RP, Novakova IR. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 1988;70:382-385.
    • (1988) J Bone Joint Surg Br , vol.70 , pp. 382-385
    • Karthaus, R.P.1    Novakova, I.R.2
  • 4
    • 0024957209 scopus 로고
    • Total knee arthroplasty for the treatment of chronic hemophilic arthropathy
    • Figgie MP, Goldberg VM, Figgie HE, et al. Total knee arthroplasty for the treatment of chronic hemophilic arthropathy. Clin Orthop. 1989;248:98-107.
    • (1989) Clin Orthop , vol.248 , pp. 98-107
    • Figgie, M.P.1    Goldberg, V.M.2    Figgie, H.E.3
  • 8
    • 0024517337 scopus 로고
    • Surgical management of advanced haemophilic arthropathy
    • Luck JV, Kasper CK. Surgical management of advanced haemophilic arthropathy. Clin Orthop. 1988;242:60-82.
    • (1988) Clin Orthop , vol.242 , pp. 60-82
    • Luck, J.V.1    Kasper, C.K.2
  • 9
    • 0022530223 scopus 로고
    • Total knee arthroplasty in chronic hemophilic arthropathy
    • Magone JB, Dennis DA, Weis LD. Total knee arthroplasty in chronic hemophilic arthropathy. Orthopedics. 1986;9:653-657.
    • (1986) Orthopedics , vol.9 , pp. 653-657
    • Magone, J.B.1    Dennis, D.A.2    Weis, L.D.3
  • 10
    • 0018741305 scopus 로고
    • Synovectomy or total replacement of the knee in hemophilia
    • McCollough NC, Enis JE, Lovitt J, et al. Synovectomy or total replacement of the knee in hemophilia. J Bone Joint Surg Br. 1979;61A:69-75.
    • (1979) J Bone Joint Surg Br , vol.61 A , pp. 69-75
    • McCollough, N.C.1    Enis, J.E.2    Lovitt, J.3
  • 11
    • 0023013537 scopus 로고
    • Long term follow-up of prosthetic joint replacement in hemophilia
    • Rana NA, Shapiro GR, Green D. Long term follow-up of prosthetic joint replacement in hemophilia. Am J Hematol. 1986;23:329-337.
    • (1986) Am J Hematol , vol.23 , pp. 329-337
    • Rana, N.A.1    Shapiro, G.R.2    Green, D.3
  • 12
    • 0020540819 scopus 로고
    • Total knee arthroplasty in hemophilic arthritis
    • Small M, Steven MM, Freeman PA, et al.Total knee arthroplasty in hemophilic arthritis. J Bone Joint Surg Br. 1983;65B:163-165.
    • (1983) J Bone Joint Surg Br , vol.65 B , pp. 163-165
    • Small, M.1    Steven, M.M.2    Freeman, P.A.3
  • 13
    • 0027157982 scopus 로고
    • Knee arthroplasty in hemophilia, 5-12 year follow-up of 15 patients
    • Teigland JC, Tjonnfjord GE, Evensen SA, et al. Knee arthroplasty in hemophilia, 5-12 year follow-up of 15 patients. Acta Orthop Scand. 1993;64:153-156.
    • (1993) Acta Orthop Scand , vol.64 , pp. 153-156
    • Teigland, J.C.1    Tjonnfjord, G.E.2    Evensen, S.A.3
  • 15
    • 0034119502 scopus 로고    scopus 로고
    • Orthopaedic outcome of total knee replacement in haemophilia A
    • Cohen I, Heim M, Martinowitz U, Chechick A. Orthopaedic outcome of total knee replacement in haemophilia A. Haemophilia. 2000;6:104-109.
    • (2000) Haemophilia , vol.6 , pp. 104-109
    • Cohen, I.1    Heim, M.2    Martinowitz, U.3    Chechick, A.4
  • 16
    • 0033375490 scopus 로고    scopus 로고
    • Haemophilic arthropathy: Assessment of quality of life after total knee arthroplasty
    • Schick M, Stucki G, Rodriguez M, et al. Haemophilic arthropathy: assessment of quality of life after total knee arthroplasty. Clin Rheumatol. 1999;18:468-472.
    • (1999) Clin Rheumatol , vol.18 , pp. 468-472
    • Schick, M.1    Stucki, G.2    Rodriguez, M.3
  • 17
    • 0031662003 scopus 로고    scopus 로고
    • Total knee and hip arthroplasty in haemophilic patients
    • Heeg M, Meyer K, Smid WM, et al.Total knee and hip arthroplasty in haemophilic patients. Haemophilia. 1998;4:747-751.
    • (1998) Haemophilia , vol.4 , pp. 747-751
    • Heeg, M.1    Meyer, K.2    Smid, W.M.3
  • 18
    • 0003080028 scopus 로고
    • The incidence of factor VIII inhibitors in patients with severe hemophilia A
    • Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II, eds. New York, NY: Plenum Press
    • Hoyer WL. The incidence of factor VIII inhibitors in patients with severe hemophilia A. In: Aledort LM, Hoyer LW, Lusher JM, Reisner HM, White GC II, eds. Inhibitors to Coagulation Factors. New York, NY: Plenum Press; 1995:35-45.
    • (1995) Inhibitors to Coagulation Factors , pp. 35-45
    • Hoyer, W.L.1
  • 19
    • 0031743504 scopus 로고    scopus 로고
    • Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
    • Shapiro AD, Gilchrist GS, Hoots WK, et al. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost. 1998;80:773-778.
    • (1998) Thromb Haemost , vol.80 , pp. 773-778
    • Shapiro, A.D.1    Gilchrist, G.S.2    Hoots, W.K.3
  • 20
    • 84980312864 scopus 로고
    • Inhibitors to factor VIII and IX
    • Brettler D. Inhibitors to factor VIII and IX. Haemophilia. 1995;1:35-39.
    • (1995) Haemophilia , vol.1 , pp. 35-39
    • Brettler, D.1
  • 21
    • 0032725116 scopus 로고    scopus 로고
    • Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa
    • Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost. 1999;82:531-539.
    • (1999) Thromb Haemost , vol.82 , pp. 531-539
    • Hedner, U.1
  • 22
    • 0033758876 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors
    • Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost. 2000;26:425-432.
    • (2000) Semin Thromb Hemost , vol.26 , pp. 425-432
    • Ingerslev, J.1
  • 23
    • 0031832066 scopus 로고    scopus 로고
    • Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven
    • Menart C, Cognet V, Petit PY, et al. Management of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of Novoseven. Blood Coagul Fibrinolysis. 1998;9:289-290.
    • (1998) Blood Coagul Fibrinolysis , vol.9 , pp. 289-290
    • Menart, C.1    Cognet, V.2    Petit, P.Y.3
  • 24
    • 0023763216 scopus 로고
    • Successful use of recombinant factor VIIa in patients with severe hemophilia A during synovectomy
    • Hedner U, Glazer S, Pingel K, et al. Successful use of recombinant factor VIIa in patients with severe hemophilia A during synovectomy. Lancet. 1988;2:1193.
    • (1988) Lancet , vol.2 , pp. 1193
    • Hedner, U.1    Glazer, S.2    Pingel, K.3
  • 25
    • 9044244906 scopus 로고    scopus 로고
    • Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa
    • Ingerslev J, Freidman D, Gastineau D, et al. Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa. Haemostasis. 1996;26:18-23.
    • (1996) Haemostasis , vol.26 , pp. 18-23
    • Ingerslev, J.1    Freidman, D.2    Gastineau, D.3
  • 26
    • 0028356496 scopus 로고
    • Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor
    • O'Marcaigh AS, Schmalz BJ, Shaughnessy WJ, Gilchrist GS. Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. Mayo Clin Proc. 1994;69:641-644.
    • (1994) Mayo Clin Proc , vol.69 , pp. 641-644
    • O'Marcaigh, A.S.1    Schmalz, B.J.2    Shaughnessy, W.J.3    Gilchrist, G.S.4
  • 27
    • 0033758468 scopus 로고    scopus 로고
    • The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa
    • Negrier C, Hay CRM. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa. Semin Thromb Hemost. 2000;26:407-412.
    • (2000) Semin Thromb Hemost , vol.26 , pp. 407-412
    • Negrier, C.1    Hay, C.R.M.2
  • 28
    • 0031759475 scopus 로고    scopus 로고
    • Experiences with continuous infusion of recombinant activated factor VII
    • Schulman S, d'Orion R, Martinowitz U, et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S97-S101.
    • (1998) Blood Coagul Fibrinolysis , vol.9 , Issue.1 SUPPL.
    • Schulman, S.1    D'Orion, R.2    Martinowitz, U.3
  • 29
    • 0033060331 scopus 로고    scopus 로고
    • Recombinant factor VIIa does not induce hypercoagulability in vitro
    • Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost. 1999;81:245-249.
    • (1999) Thromb Haemost , vol.81 , pp. 245-249
    • Gallistl, S.1    Cvirn, G.2    Muntean, W.3
  • 30
    • 0033764370 scopus 로고    scopus 로고
    • The factor VII-platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
    • Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost. 2000;26:373-377.
    • (2000) Semin Thromb Hemost , vol.26 , pp. 373-377
    • Monroe, D.M.1    Hoffman, M.2    Allen, G.A.3    Roberts, H.R.4
  • 31
    • 0034935085 scopus 로고    scopus 로고
    • High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system
    • Kjalke M, Ezban M, Monroe DM, et al. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. Br J Haematol. 2001;114:114-120.
    • (2001) Br J Haematol , vol.114 , pp. 114-120
    • Kjalke, M.1    Ezban, M.2    Monroe, D.M.3
  • 32
    • 0017601513 scopus 로고
    • Mass-length ratio of fibrin fibers from gel permeation and light scattering
    • Carr ME, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers. 1977;16:1-15.
    • (1977) Biopolymers , vol.16 , pp. 1-15
    • Carr, M.E.1    Shen, L.L.2    Hermans, J.3
  • 33
    • 0017910967 scopus 로고
    • Size and density of fibrin fibers from turbidity
    • Carr ME Jr, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 1978;11:46-50.
    • (1978) Macromolecules , vol.11 , pp. 46-50
    • Carr Jr., M.E.1    Hermans, J.2
  • 34
    • 0024410071 scopus 로고
    • Native fibrin gel networks observed by 3D microscopy, permeation and turbidity
    • Blomback B, Carlsson K, Hessel B, et al. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
    • (1989) Biochim Biophys Acta , vol.997 , pp. 96-110
    • Blomback, B.1    Carlsson, K.2    Hessel, B.3
  • 35
    • 0024241291 scopus 로고
    • Strain enhancement of elastic modulus in fine fibrin clots
    • Bale MD, Ferry JD. Strain enhancement of elastic modulus in fine fibrin clots. Thromb Res. 1988;52:565-572.
    • (1988) Thromb Res , vol.52 , pp. 565-572
    • Bale, M.D.1    Ferry, J.D.2
  • 36
    • 0028156672 scopus 로고
    • Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma
    • Carr ME Jr, Zekert SL. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am J Physiol. 1994;266:H1195-H1201.
    • (1994) Am J Physiol , vol.266
    • Carr Jr., M.E.1    Zekert, S.L.2
  • 37
    • 0026491075 scopus 로고
    • The effect of fibrin structure on fibrinolysis
    • Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem. 1992;267:24259-24263.
    • (1992) J Biol Chem , vol.267 , pp. 24259-24263
    • Gabriel, D.A.1    Muga, K.2    Boothroyd, E.M.3
  • 38
    • 16044368230 scopus 로고    scopus 로고
    • Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma
    • Carr ME Jr, Dent RM, Carr SL. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma. J Lab Clin Med. 1996;128:83-88.
    • (1996) J Lab Clin Med , vol.128 , pp. 83-88
    • Carr Jr., M.E.1    Dent, R.M.2    Carr, S.L.3
  • 39
    • 0034022885 scopus 로고    scopus 로고
    • Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy
    • Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1354-1361
    • Collet, J.P.1    Park, D.2    Lesty, C.3
  • 40
    • 0034977041 scopus 로고    scopus 로고
    • Clot lysis of variant recombinant fibrinogens confirms that fiber diameter is a major determinant of lysis rate
    • Mullin JL, Norfolk SE, Weisel JW, Lord ST. Clot lysis of variant recombinant fibrinogens confirms that fiber diameter is a major determinant of lysis rate. Ann NY Acad Sci. 2001;936:331-334.
    • (2001) Ann NY Acad Sci , vol.936 , pp. 331-334
    • Mullin, J.L.1    Norfolk, S.E.2    Weisel, J.W.3    Lord, S.T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.